Abstract
Heart failure is a leading cause of morbidity and mortality, the incidence of which is predicted to continue to increase as the population ages. Left ventricular assist devices (LVADs) in particular have emerged as important therapies for the support of patients with advanced heart failure needing short- or long-term mechanical circulatory support. With over 5000 implantations per year, LVADs are the most commonly used durable devices worldwide. In this article, we provide an overview of the intensive care management of patients with LVADs during the early post-implantation period.
Similar content being viewed by others
References
Mehra MR, Goldstein DJ, Uriel N, et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378:1386–95.
Han JJ, Acker MA, Atluri P. Left ventricular assist devices. Circulation. 2018;138:2841–51.
Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36:1080–6. https://doi.org/10.1016/j.healun.2017.07.005.
Tchoukina I, Smallfield MC, Shah KB. Device management and flow optimization on left ventricular assist device support. Crit Care Clin. 2018;34:453–63.
Slaughter MS. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy. J Card Surg. 2010;25:490–4.
Nepomuceno RG, Goldraich LA, De S, et al. Critical care management of the acute postimplant LVAD patient. Can J Cardiol. 2020;36:313–6.
Roberts SM, Hovord DG, Kodavatiganti R, Sathishkumar S. Ventricular assist devices and non-cardiac surgery. BMC Anesthesiol. 2015;15:185.
Sen A, Larson JS, Kashani KB, et al. Mechanical circulatory assist devices: a primer for critical care and emergency physicians. Crit Care. 2016;20:153.
Huard P, Kalavrouziotis D, Lipes J, et al. Does the full-time presence of an intensivist lead to better outcomes in the cardiac surgical intensive care unit? J Thorac Cardiovasc Surg. 2020;159:1363-1375.e7.
Benoit MA, Bagshaw SM, Norris CM, et al. Postoperative complications and outcomes associated with a transition to 24/7 intensivist management of cardiac surgery patients. Crit Care Med. 2017;45:993–1000.
Liu H, Jones TE, Jeng E, Peng KL, Peng YG. Risk stratification and optimization to prevent right heart failure during left ventricular assist device implantation. J Cardiothorac Vasc Anesth. 2021;35:3385–93.
Addetia K, Lang R, Patel A, Mor-Avi V, Spencer K. Abstract 13965: Are TAPSE and S’ reliable measures of right ventricular performance? Circulation. 2013;128:A13965.
Unsworth B, Casula RP, Kyriacou AA, et al. The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incision. Am Heart J. 2010;159:314–22.
Angleitner P, Simon P, Kaider A, et al. Impact of bleeding revision on outcomes after left ventricular assist device implantation. Ann Thorac Surg. 2019;108:517–23.
Leebeek FWG, Muslem R. Bleeding in critical care associated with left ventricular assist devices: pathophysiology, symptoms, and management. Hematology Am Soc Hematol Educ Program. 2019;2019:88–96.
Whitehouse KR, Avula D, Kahlon T, et al. Apixaban: alternative anticoagulation for HeartMate 3 ventricular assist device. ASAIO J. 2022;68:318–22.
Currigan DA, Hughes RJA, Wright CE, Angus JA, Soeding PF. Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study. Anesthesiology. 2014;121:930–6.
Koo B, Wang D, Guerrero Miranda C, Negassa A, Tauras J. Abstract 14068: Effect of tricuspid regurgitation on thermodilution cardiac output assessment. Circulation. 2016;134:A14068.
Bonno EL, Viray MC, Jackson GR, Houston BA, Tedford RJ. Modern right heart catheterization: beyond simple hemodynamics. Adv Pulm hypertens. 2020;19:6–15.
Ali H-JR, Kiernan MS, Choudhary G, et al. Right ventricular failure post-implantation of left ventricular assist device: prevalence, pathophysiology, and predictors. ASAIO J. 2020;66:610–9.
Handoko ML, De Man FS, Oosterveer FPT, Bogaard H-J, Vonk-Noordegraaf A, Westerhof N. A critical appraisal of transpulmonary and diastolic pressure gradients. Physiol Rep. 2016;4:e12910.
Collier TE, Kataria V, Modrykamien A. Inhaled epoprostenol utilization pattern after implementation of an administration policy. Proc (Bayl Univ Med Cent). 2019;33:10–4.
Blanco I, Gimeno E, Munoz PA, et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med. 2010;181:270–8.
Li S, Beckman JA, Welch NG, et al. Accuracy of Doppler blood pressure measurement in continuous-flow left ventricular assist device patients. ESC Heart Fail. 2019;6:793–8.
Coromilas EJ, Takeda K, Ando M, et al. Comparison of percutaneous and surgical right ventricular assist device support after durable left ventricular assist device insertion. J Card Fail. 2019;25:105–13.
Kiernan MS, Grandin EW, Brinkley M, et al. Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation: incidence and risk factors from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail. 2017;10:e003863.
Wang Y, Simon MA, Bonde P, et al. Decision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device. J Heart Lung Transplant. 2012;31:140–9.
Patil NP, Mohite PN, Sabashnikov A, et al. Preoperative predictors and outcomes of right ventricular assist device implantation after continuous-flow left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2015;150:1651–8.
Amato MBP, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372:747–55.
Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8.
Fischer M-O, Brotons F, Briant AR, et al. Postoperative pulmonary complications after cardiac surgery: the VENICE International Cohort Study. J Cardiothorac Vasc Anesth. 2022;36:2344–51.
Caroff DA, Li L, Muscedere J, Klompas M. Subglottic secretion drainage and objective outcomes: a systematic review and meta-analysis. Crit Care Med. 2016;44:830–40.
Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry: 2011. Respir Care. 2011;56:1600–4.
Lafortuna CL, Fazio F. Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis. Respiration. 1984;45:111–23.
Frohock JI, Wijkstrom-Frei C, Salathe M. Effects of albuterol enantiomers on ciliary beat frequency in ovine tracheal epithelial cells. J Appl Physiol (1985).2002;92:2396-402.
Huynh TT, Liesching TN, Cereda M, et al. Efficacy of oscillation and lung expansion in reducing postoperative pulmonary complication. J Am Coll Surg. 2019;229:458-466.e1.
Romeiro FG, Okoshi K, Zornoff LAM, Okoshi MP. Gastrointestinal changes associated to heart failure. Arq Bras Cardiol. 2012;98:273–7.
Krack A, Sharma R, Figulla HR, Anker SD. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J. 2005;26:2368–74.
Corey S, Sean PP, Hung-Mo L, et al. Safety of parenteral nutrition in patients receiving a ventricular assist device. ASAIO J. 2014;60:376–80.
Harvey L, Holley CT, John R. Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Ann Cardiothorac Surg. 2014;3:475–9.
Goldstein DJ, Naka Y, Horstmanshof D, et al. Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3) randomized clinical trial. JAMA Cardiol. 2020;5:411–9.
Taube C, Holz O, Mücke M, Jörres RA, Magnussen H. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1810–5.
Albrecht HH, Dicpinigaitis PV, Guenin EP. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. Multidiscip Respir Med. 2017;12:31.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Ethical board approval was not required for this review article.
Informed consent
As no patient information was utilized for this review article, no informed consent was required.
Conflict of interest
The authors declare no conflicts of interest.
Statement of human and animal rights
This review article does not contain studies with human or animal participants performed by any of the authors.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Baronos, S., Whitford, R.C. & Adkins, K. Postoperative care after left ventricular assist device implantation: considerations for the cardiac surgical intensivist. Indian J Thorac Cardiovasc Surg 39 (Suppl 1), 182–189 (2023). https://doi.org/10.1007/s12055-022-01434-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-022-01434-y